|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.998
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
72 |
0.978
|
|
|
|
innate immune response activating signal transduction
|
GO:0002758 |
50 |
0.968
|
|
|
|
regulation of antigen receptor mediated signaling pathway
|
GO:0050854 |
29 |
0.965
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.956
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.955
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.933
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.926
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.897
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.892
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.887
|
|
|
|
activation of innate immune response
|
GO:0002218 |
56 |
0.845
|
|
|
|
interferon beta biosynthetic process
|
GO:0045350 |
4 |
0.782
|
|
|
|
toll like receptor signaling pathway
|
GO:0002224 |
38 |
0.762
|
|
|
|
lymphocyte homeostasis
|
GO:0002260 |
64 |
0.745
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.743
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.742
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.739
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.737
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.727
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.700
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.676
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.656
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.635
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.631
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.631
|
|
|
|
lipopolysaccharide mediated signaling pathway
|
GO:0031663 |
25 |
0.626
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.615
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.602
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.597
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.595
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.551
|
|
|
|
positive regulation of b cell activation
|
GO:0050871 |
49 |
0.547
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.530
|
|
|
|
myeloid dendritic cell differentiation
|
GO:0043011 |
16 |
0.495
|
|
|
|
pattern recognition receptor signaling pathway
|
GO:0002221 |
47 |
0.492
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.490
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.463
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.456
|
|
|
|
b cell receptor signaling pathway
|
GO:0050853 |
20 |
0.453
|
|
|
|
regulation of b cell proliferation
|
GO:0030888 |
39 |
0.451
|
|
|
|
positive regulation of interleukin 12 production
|
GO:0032735 |
21 |
0.430
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.426
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.425
|
|
|
|
nucleotide binding oligomerization domain containing signaling pathway
|
GO:0070423 |
6 |
0.425
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.421
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.410
|
|
|
|
b cell proliferation
|
GO:0042100 |
53 |
0.410
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.401
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.381
|
|
|
|
interferon gamma production
|
GO:0032609 |
67 |
0.377
|
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.369
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.362
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.352
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.348
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.344
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.343
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.343
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.330
|
|
|
|
cytoplasmic pattern recognition receptor signaling pathway
|
GO:0002753 |
10 |
0.328
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.326
|
|
|
|
immunoglobulin mediated immune response
|
GO:0016064 |
69 |
0.325
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.324
|
|
|
|
positive regulation of phospholipase c activity
|
GO:0010863 |
2 |
0.316
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.310
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.309
|
|
|
|
regulation of cytokine biosynthetic process
|
GO:0042035 |
59 |
0.306
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.303
|
|
|
|
natural killer cell activation
|
GO:0030101 |
44 |
0.286
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.280
|
|
|
|
regulation of blood coagulation
|
GO:0030193 |
28 |
0.277
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
64 |
0.272
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.261
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.259
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.259
|
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.258
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.254
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.252
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.246
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.246
|
|
|
|
positive regulation of b cell proliferation
|
GO:0030890 |
24 |
0.243
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.241
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.239
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.239
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.237
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.237
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.231
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.230
|
|
|
|
negative regulation of antigen receptor mediated signaling pathway
|
GO:0050858 |
16 |
0.229
|
|
|
|
detection of mechanical stimulus involved in sensory perception of pain
|
GO:0050966 |
4 |
0.228
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.227
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.227
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.227
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.227
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.225
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.223
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.221
|
|
|
|
regulation of hemostasis
|
GO:1900046 |
28 |
0.219
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.216
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.212
|
Zebrafish |
|
|
positive regulation of gamma delta t cell differentiation
|
GO:0045588 |
6 |
0.210
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.207
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.204
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.203
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.201
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.200
|
|
|
|
platelet morphogenesis
|
GO:0036344 |
13 |
0.198
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.192
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
49 |
0.188
|
|
|
|
regulation of phospholipase c activity
|
GO:1900274 |
3 |
0.188
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.187
|
|
|
|
b cell homeostasis
|
GO:0001782 |
34 |
0.181
|
|
|
|
defense response to virus
|
GO:0051607 |
68 |
0.180
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.180
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.178
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
61 |
0.177
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.177
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.177
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.175
|
|
|
|
positive regulation of leukocyte apoptotic process
|
GO:2000108 |
21 |
0.174
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.174
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.174
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.169
|
|
|
|
regulation of nucleotide binding oligomerization domain containing 1 signaling pathway
|
GO:0070428 |
3 |
0.168
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.167
|
|
|
|
tumor necrosis factor production
|
GO:0032640 |
50 |
0.166
|
|
|
|
cellular response to fibroblast growth factor stimulus
|
GO:0044344 |
47 |
0.166
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.166
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.165
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.165
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.162
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.162
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.162
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.158
|
Fly |
|
|
germ cell development
|
GO:0007281 |
185 |
0.156
|
Fly |
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.155
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.153
|
|
|
|
platelet degranulation
|
GO:0002576 |
6 |
0.151
|
|
|
|
positive regulation of hemostasis
|
GO:1900048 |
10 |
0.148
|
|
|
|
positive regulation of leukocyte mediated immunity
|
GO:0002705 |
70 |
0.145
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.145
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.144
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.143
|
Fly |
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.143
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.141
|
|
|
|
regulation of actin polymerization or depolymerization
|
GO:0008064 |
45 |
0.141
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.140
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.139
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.138
|
|
|
|
regulation of platelet activation
|
GO:0010543 |
17 |
0.138
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.137
|
|
|
|
megakaryocyte differentiation
|
GO:0030219 |
26 |
0.135
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.134
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.134
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.132
|
|
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
1 |
0.132
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.129
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.129
|
|
|
|
myeloid dendritic cell activation
|
GO:0001773 |
25 |
0.129
|
|
|
|
response to retinoic acid
|
GO:0032526 |
56 |
0.128
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.124
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.123
|
|
|
|
positive regulation of lipopolysaccharide mediated signaling pathway
|
GO:0031666 |
5 |
0.121
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.119
|
|
|
|
filtration diaphragm assembly
|
GO:0036058 |
1 |
0.119
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.119
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.118
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.116
|
|
|
|
regulation of erythrocyte differentiation
|
GO:0045646 |
23 |
0.115
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.114
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.114
|
|
|
|
regulation of podosome assembly
|
GO:0071801 |
3 |
0.114
|
|
|
|
nucleotide binding oligomerization domain containing 2 signaling pathway
|
GO:0070431 |
6 |
0.113
|
|
|
|
regulation of interferon beta biosynthetic process
|
GO:0045357 |
4 |
0.113
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.112
|
|
|
|
negative regulation of map kinase activity
|
GO:0043407 |
34 |
0.112
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.110
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.109
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.107
|
|
|
|
regulation of homotypic cell cell adhesion
|
GO:0034110 |
13 |
0.107
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.104
|
|
|
|
regulation of mast cell degranulation
|
GO:0043304 |
16 |
0.103
|
|
|
|
response to molecule of fungal origin
|
GO:0002238 |
4 |
0.103
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.102
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.101
|
|
|
|
platelet activation
|
GO:0030168 |
40 |
0.100
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.100
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.100
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.100
|
|
|
|
b cell mediated immunity
|
GO:0019724 |
71 |
0.099
|
|
|
|
nucleotide binding oligomerization domain containing 1 signaling pathway
|
GO:0070427 |
5 |
0.099
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.099
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.098
|
|
|
|
b cell activation involved in immune response
|
GO:0002312 |
50 |
0.098
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.097
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.097
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.097
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.097
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.097
|
Human |
|
|
organelle assembly
|
GO:0070925 |
177 |
0.096
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.096
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.096
|
|
|
|
myd88 independent toll like receptor signaling pathway
|
GO:0002756 |
3 |
0.096
|
|
|
|
nucleotide binding domain leucine rich repeat containing receptor signaling pathway
|
GO:0035872 |
6 |
0.094
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.094
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.093
|
|
|
|
positive regulation of interferon beta production
|
GO:0032728 |
8 |
0.093
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.093
|
|
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
53 |
0.092
|
|
|
|
actin cytoskeleton reorganization
|
GO:0031532 |
21 |
0.092
|
|
|
|
regulation of toll like receptor 4 signaling pathway
|
GO:0034143 |
4 |
0.091
|
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.091
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.090
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.089
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.089
|
|
|
|
antimicrobial peptide biosynthetic process
|
GO:0002777 |
2 |
0.088
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.088
|
Fly |
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.087
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.087
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.087
|
|
|
|
regulation of interleukin 6 production
|
GO:0032675 |
55 |
0.087
|
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
46 |
0.087
|
|
|
|
somatic diversification of immune receptors via germline recombination within a single locus
|
GO:0002562 |
51 |
0.086
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.086
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.086
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.085
|
|
|
|
somatic cell dna recombination
|
GO:0016444 |
51 |
0.085
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.083
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.083
|
|
|
|
type i interferon production
|
GO:0032606 |
29 |
0.082
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.082
|
|
|
|
interferon beta production
|
GO:0032608 |
16 |
0.082
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.082
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.082
|
|
|
|
platelet aggregation
|
GO:0070527 |
20 |
0.081
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.080
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.080
|
|
|
|
neutrophil differentiation
|
GO:0030223 |
3 |
0.079
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.078
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.078
|
|
|
|
syncytium formation
|
GO:0006949 |
43 |
0.078
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.078
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.078
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.078
|
|
|
|
positive regulation of podosome assembly
|
GO:0071803 |
3 |
0.078
|
|
|
|
negative regulation of toll like receptor signaling pathway
|
GO:0034122 |
14 |
0.078
|
|
|
|
b cell apoptotic process
|
GO:0001783 |
19 |
0.077
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.077
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.077
|
|
|
|
positive regulation of lymphocyte mediated immunity
|
GO:0002708 |
62 |
0.077
|
|
|
|
positive regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903557 |
31 |
0.076
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.076
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.075
|
|
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
50 |
0.075
|
|
|
|
regulation of toll like receptor 2 signaling pathway
|
GO:0034135 |
3 |
0.075
|
|
|
|
regulation of lipid transport
|
GO:0032368 |
36 |
0.074
|
|
|
|
pyrimidine containing compound metabolic process
|
GO:0072527 |
11 |
0.074
|
|
|
|
regulation of interferon gamma production
|
GO:0032649 |
57 |
0.074
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.074
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.073
|
|
|
|
regulation of coagulation
|
GO:0050818 |
31 |
0.073
|
|
|
|
interleukin 6 production
|
GO:0032635 |
58 |
0.072
|
|
|
|
macrophage derived foam cell differentiation
|
GO:0010742 |
6 |
0.072
|
|
|
|
positive regulation of jnk cascade
|
GO:0046330 |
46 |
0.072
|
|
|
|
hair cell differentiation
|
GO:0035315 |
40 |
0.071
|
|
|
|
positive regulation of interferon alpha production
|
GO:0032727 |
4 |
0.070
|
|
|
|
regulation of dendritic cell apoptotic process
|
GO:2000668 |
3 |
0.070
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.070
|
|
|
|
lymphocyte apoptotic process
|
GO:0070227 |
54 |
0.069
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.069
|
Human |
|
|
regionalization
|
GO:0003002 |
337 |
0.069
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.069
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.069
|
|
|
|
negative regulation of humoral immune response mediated by circulating immunoglobulin
|
GO:0002924 |
3 |
0.069
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.069
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.069
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.069
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.068
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.068
|
|
|
|
mast cell proliferation
|
GO:0070662 |
4 |
0.068
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.068
|
|
|
|
regulation of chemokine production
|
GO:0032642 |
30 |
0.067
|
|
|
|
somatic recombination of immunoglobulin gene segments
|
GO:0016447 |
42 |
0.067
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.067
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.066
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.066
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.066
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.066
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.065
|
|
|
|
hypermethylation of cpg island
|
GO:0044027 |
3 |
0.065
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.065
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.065
|
|
|
|
macrophage differentiation
|
GO:0030225 |
20 |
0.065
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.065
|
|
|
|
cellular response to retinoic acid
|
GO:0071300 |
25 |
0.065
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.065
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.064
|
|
|
|
antigen processing and presentation
|
GO:0019882 |
47 |
0.064
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.063
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.062
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.062
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.061
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.060
|
|
|
|
regulation of natural killer cell activation
|
GO:0032814 |
22 |
0.060
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.060
|
|
|
|
positive regulation of blood coagulation
|
GO:0030194 |
10 |
0.060
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.059
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.059
|
Human |
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.059
|
|
|
|
negative regulation of lymphocyte proliferation
|
GO:0050672 |
45 |
0.059
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.058
|
|
|
|
regulation of lipid kinase activity
|
GO:0043550 |
14 |
0.058
|
|
|
|
antibacterial peptide production
|
GO:0002778 |
2 |
0.058
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.058
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.058
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.058
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.057
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.057
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.057
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.057
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.057
|
|
|
|
positive regulation of chemokine production
|
GO:0032722 |
22 |
0.057
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.056
|
|
|
|
negative regulation of mast cell proliferation
|
GO:0070667 |
1 |
0.056
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.056
|
Fly |
|
|
immune response inhibiting cell surface receptor signaling pathway
|
GO:0002767 |
3 |
0.056
|
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.055
|
|
|
|
positive regulation of myeloid leukocyte differentiation
|
GO:0002763 |
26 |
0.055
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.055
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.055
|
|
|
|
regulation of tumor necrosis factor biosynthetic process
|
GO:0042534 |
10 |
0.055
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.054
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.054
|
|
|
|
spindle localization
|
GO:0051653 |
22 |
0.054
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.054
|
|
|
|
positive regulation of antimicrobial peptide production
|
GO:0002225 |
1 |
0.054
|
|
|
|
natural killer cell mediated immunity
|
GO:0002228 |
29 |
0.054
|
|
|
|
gamma delta t cell differentiation
|
GO:0042492 |
11 |
0.054
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.053
|
|
|
|
regulation of retina development in camera type eye
|
GO:1902866 |
3 |
0.053
|
|
|
|
regulation of interferon beta production
|
GO:0032648 |
13 |
0.053
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.053
|
|
|
|
regulation of mast cell proliferation
|
GO:0070666 |
4 |
0.053
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.052
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.052
|
Zebrafish |
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.052
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.052
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
38 |
0.052
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.052
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.051
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.051
|
|
|
|
positive regulation of b cell receptor signaling pathway
|
GO:0050861 |
4 |
0.050
|
|
|
|
mast cell mediated immunity
|
GO:0002448 |
20 |
0.050
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.050
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.050
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.050
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.049
|
|
|
|
regulation of t cell receptor signaling pathway
|
GO:0050856 |
21 |
0.049
|
|
|
|
positive regulation of phosphatidylinositol 3 kinase activity
|
GO:0043552 |
11 |
0.049
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.049
|
|
|
|
induction by organism of immune response of other organism involved in symbiotic interaction
|
GO:0052558 |
1 |
0.049
|
|
|
|
natural killer cell mediated cytotoxicity
|
GO:0042267 |
29 |
0.049
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.048
|
|
|
|
innate immune response activating cell surface receptor signaling pathway
|
GO:0002220 |
4 |
0.048
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.048
|
|
|
|
peptidyl tyrosine dephosphorylation
|
GO:0035335 |
23 |
0.048
|
|
|
|
release of sequestered calcium ion into cytosol
|
GO:0051209 |
42 |
0.048
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.048
|
Human |
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.048
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.048
|
|
|
|
substrate adhesion dependent cell spreading
|
GO:0034446 |
30 |
0.048
|
|
|
|
endodermal cell fate commitment
|
GO:0001711 |
12 |
0.048
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.048
|
|
|
|
negative regulation of erk1 and erk2 cascade
|
GO:0070373 |
21 |
0.047
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.047
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.047
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.047
|
|
|
|
activation of rac gtpase activity
|
GO:0032863 |
2 |
0.047
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.047
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.047
|
|
|
|
negative regulation of interleukin 13 secretion
|
GO:2000666 |
1 |
0.046
|
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.046
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway
|
GO:2001238 |
34 |
0.046
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.046
|
|
|
|
regulation of cd8 positive alpha beta t cell activation
|
GO:2001185 |
3 |
0.046
|
|
|
|
positive regulation of stress activated mapk cascade
|
GO:0032874 |
48 |
0.046
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.046
|
|
|
|
integrin mediated signaling pathway
|
GO:0007229 |
27 |
0.046
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.046
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.046
|
|
|
|
cd4 positive or cd8 positive alpha beta t cell lineage commitment
|
GO:0043369 |
8 |
0.046
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.045
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.045
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.045
|
|
|
|
somatic diversification of immunoglobulins involved in immune response
|
GO:0002208 |
36 |
0.044
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.044
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.044
|
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.044
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.044
|
Fly |
|
|
positive regulation of macrophage chemotaxis
|
GO:0010759 |
5 |
0.044
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.043
|
|
|
|
regulation of cell shape
|
GO:0008360 |
39 |
0.043
|
Fly |
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.042
|
|
|
|
regulation of b cell apoptotic process
|
GO:0002902 |
13 |
0.042
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.042
|
|
|
|
response to platelet derived growth factor
|
GO:0036119 |
6 |
0.042
|
|
|
|
establishment of spindle localization
|
GO:0051293 |
19 |
0.042
|
|
|
|
homotypic cell cell adhesion
|
GO:0034109 |
28 |
0.042
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.042
|
|
|
|
immune response inhibiting signal transduction
|
GO:0002765 |
4 |
0.042
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.042
|
|
|
|
substrate dependent cell migration
|
GO:0006929 |
18 |
0.042
|
|
|
|
positive regulation of type i interferon production
|
GO:0032481 |
14 |
0.041
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.041
|
|
|
|
regulation of phosphatidylinositol 3 kinase activity
|
GO:0043551 |
14 |
0.041
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.041
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.041
|
|
|
|
regulation of response to biotic stimulus
|
GO:0002831 |
38 |
0.041
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.040
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.040
|
|
|
|
regulation of bone resorption
|
GO:0045124 |
24 |
0.040
|
|
|
|
positive regulation of osteoclast differentiation
|
GO:0045672 |
15 |
0.040
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.040
|
|
|
|
regulation of notch signaling pathway
|
GO:0008593 |
35 |
0.040
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.040
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.040
|
|
|
|
labyrinthine layer blood vessel development
|
GO:0060716 |
21 |
0.040
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.039
|
|
|
|
fc receptor mediated inhibitory signaling pathway
|
GO:0002774 |
1 |
0.039
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.039
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.039
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.039
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.039
|
|
|
|
response to dsrna
|
GO:0043331 |
30 |
0.039
|
|
|
|
somatic diversification of immunoglobulins
|
GO:0016445 |
43 |
0.039
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.039
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.039
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.039
|
|
|
|
positive regulation of interferon gamma production
|
GO:0032729 |
39 |
0.038
|
|
|
|
t cell receptor signaling pathway
|
GO:0050852 |
46 |
0.038
|
Mouse |
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.038
|
|
|
|
negative regulation of notch signaling pathway
|
GO:0045746 |
14 |
0.038
|
|
|
|
response to defense related nitric oxide production by other organism involved in symbiotic interaction
|
GO:0052551 |
2 |
0.038
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.038
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.038
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.038
|
|
|
|
negative regulation of interleukin 6 production
|
GO:0032715 |
17 |
0.037
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.037
|
|
|
|
positive regulation of antimicrobial humoral response
|
GO:0002760 |
2 |
0.037
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.037
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.037
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.037
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.037
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.037
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.036
|
|
|
|
toll like receptor 4 signaling pathway
|
GO:0034142 |
9 |
0.036
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.036
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.036
|
|
|
|
regulation of type i interferon production
|
GO:0032479 |
22 |
0.036
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.036
|
Zebrafish |
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.036
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.036
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.036
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.036
|
|
|
|
positive regulation of interleukin 18 production
|
GO:0032741 |
2 |
0.036
|
|
|
|
microglia differentiation
|
GO:0014004 |
2 |
0.036
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.036
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.035
|
|
|
|
negative regulation of toll like receptor 2 signaling pathway
|
GO:0034136 |
3 |
0.035
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.035
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.035
|
|
|
|
myeloid cell activation involved in immune response
|
GO:0002275 |
34 |
0.035
|
|
|
|
cellular response to peptidoglycan
|
GO:0071224 |
4 |
0.035
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.035
|
|
|
|
regulation of cellular response to oxidative stress
|
GO:1900407 |
19 |
0.035
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.034
|
|
|
|
regulation of defense response to fungus
|
GO:1900150 |
1 |
0.034
|
|
|
|
i kappab phosphorylation
|
GO:0007252 |
6 |
0.034
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.034
|
|